dc.contributor.author | Sevmis, M. | |
dc.contributor.author | Sevmis, S. | |
dc.contributor.author | Aktas, S. | |
dc.contributor.author | Khalilov, M. | |
dc.contributor.author | Demir, M.E. | |
dc.date.accessioned | 2021-12-21T08:40:45Z | |
dc.date.available | 2021-12-21T08:40:45Z | |
dc.date.issued | 2020 | |
dc.identifier.issn | 411345 | |
dc.identifier.uri | https://doi.org/10.1016/j.transproceed.2020.01.014 | |
dc.identifier.uri | http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1182 | |
dc.description.abstract | Background: The existence of renal cell cancer (RCC) in a donated kidney may cause some confusion for clinicians. We aim to present our clinical experiences with 2 recipients who received an RCC-containing kidney from their living related donors. Methods: | |
dc.language.iso | English | |
dc.publisher | Elsevier USA | |
dc.title | Kidney Transplantation From Donors with Resectable Renal Cell Carcinoma: Two Case Reports | |
dc.type | Article | |
dc.relation.journal | Transplantation Proceedings | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 737 | |
dc.identifier.endpage | 739 | |
dc.identifier.volume | 52 | |
dc.identifier.doi | 10.1016/j.transproceed.2020.01.014 | |
dc.relation.issue | 3 | |
dc.relation.volume | 52 | |